Home/Filings/4/0001209191-20-042203
4//SEC Filing

Andrews William T. 4

Accession 0001209191-20-042203

CIK 0001662524other

Filed

Jul 9, 8:00 PM ET

Accepted

Jul 10, 5:31 PM ET

Size

7.1 KB

Accession

0001209191-20-042203

Insider Transaction Report

Form 4
Period: 2020-07-09
Andrews William T.
Chief Medical Officer
Transactions
  • Award

    Stock Option (right to buy)

    2020-07-09+250,000250,000 total
    Exercise: $13.29Exp: 2030-07-08Common Stock (250,000 underlying)
  • Award

    Common Stock

    2020-07-09+37,50037,500 total
Footnotes (2)
  • [F1]Represents restricted stock unit award granted under the Issuer's 2015 Equity Incentive Plan.
  • [F2]The shares vest as follows: 1/4th of the shares vest one year after July 9, 2020; 1/48th of the shares vest monthly thereafter over the next three years.

Issuer

AKCEA THERAPEUTICS, INC.

CIK 0001662524

Entity typeother

Related Parties

1
  • filerCIK 0001638459

Filing Metadata

Form type
4
Filed
Jul 9, 8:00 PM ET
Accepted
Jul 10, 5:31 PM ET
Size
7.1 KB